Professor Heikki Joensuu appointed as VP of Oncology R&D in Orion


Nov 7 2017

SPARK Finland, Sartar Therapeutics, Heikki Joensuu, Orion

Professor Heikki Joensuu, M.D., Ph.D., has been appointed Vice President of Therapy area Oncology, R&D in Orion Corporation as of 1 December 2017. He joins Orion from the Comprehensive Cancer Center, Helsinki University Hospital, where he worked as the Research Director from 2015 to 2017.

Prior to that, he was Research Professor of the Academy of Finland from 2010 to 2014. At present he is the Director of the Laboratory of Molecular Oncology, Biomedicum, Helsinki, and his research group is a part of a Center of Excellence of the Academy of Finland.

The main topics of his clinical and translational research have been breast cancer and gastrointestinal stromal tumour (GIST). He has received several national and international science awards.

He is also a co-founder and scientific advisor of Sartar Therapeutics which is one of the participants in SPARK Finland program.

On behalf of SPARK Finland we want to congratulate Heikki for the appointment and look forward continuing active collaboration with cancer drug development.

Read more